Oncoscience

Volume 5: Issue 5-6

pp120-208

Issue 5-6

About the Cover

The cover for this issue of Oncoscience features Figure 1 from "A new concept in NF2 pharmacotherapy: targeting fatty acid synthesis" Stepanova et al.

Editorials

Targeting MYC for triple-negative breast cancer treatment

https://doi.org/10.18632/oncoscience.414

Nancy  Klauber-DeMore, Bradley A. Schulte, Gavin Y. Wang

p 120-121

PDF

BETter together: exploiting BRD4-functions in transcription to inform rational combinations

https://doi.org/10.18632/oncoscience.415

Fabio  Savarese, Norbert  Kraut

p 122-123

PDF

Personalized medicine: exploiting druggable vulnerabilities for KRAS-driven lung cancer

https://doi.org/10.18632/oncoscience.416

Laetitia  Seguin, Chloé  Féral

p 124-125

PDF

A new concept in NF2 pharmacotherapy: targeting fatty acid synthesis

https://doi.org/10.18632/oncoscience.417

Dina S. Stepanova, Lanita  Braun, Jonathan  Chernoff

p 126-127

PDF

The pro-tumoral function of HACE1

https://doi.org/10.18632/oncoscience.418

Najla  El-Hachem, Robert  Ballotti

p 128-129

PDF

Poldip2 takes a central role in metabolic reprograming

https://doi.org/10.18632/oncoscience.419

Felipe  Paredes, Izabela  Suster, Alejra San Martin

p 130-131

PDF

Curing cancer? Further along the new pH-centric road and paradigm

https://doi.org/10.18632/oncoscience.422

S.  Harguindey, T.  Koltai, S. J. Reshkin

p 132-133

PDF

Combating resistance to DNA damaging agents

https://doi.org/10.18632/oncoscience.423

Jung-Suk  Choi, Anthony  Berdis

p 134-136

PDF

Leveraging MYC as a therapeutic treatment option for TNBC

https://doi.org/10.18632/oncoscience.424

Jason P.W. Carey, Khan  Keyomarsi

p 137-139

PDF

Advances in biomarkers and treatment strategies for HPV-associated head and neck cancer

https://doi.org/10.18632/oncoscience.425

Cassie  Pan, Wendell G. Yarbrough, Natalia  Issaeva

p 140-141

PDF

Metastasis-associated upregulation of ER-Golgi trafficking kinetics: regulation of cancer progression via the Golgi apparatus

https://doi.org/10.18632/oncoscience.426

Breege V. Howley, Philip H. Howe

p 142-143

PDF

Targeting p27 tyrosine phosphorylation as a modality to inhibit CDK4 and CDK2 and cause cell cycle arrest in breast cancer cells

https://doi.org/10.18632/oncoscience.427

Stacy W. Blain

p 144-145

PDF

Adipocyte metabolism of the chemotherapy daunorubicin

https://doi.org/10.18632/oncoscience.428

Steven D. Mittelman, Etan  Orgel

p 146-147

PDF

NEO212: sub-cytotoxic doses capable of inhibiting glioma stem cell invasion

https://doi.org/10.18632/oncoscience.429

Nagore I. Marín-Ramos, Florence M. Hofman, Thomas C. Chen

p 148-149

PDF

VEGF-mTOR signaling links obesity and endometrial cancer

https://doi.org/10.18632/oncoscience.430

Subhransu S. Sahoo, Pradeep S. Tanwar

p 150-151

PDF

Targeting Cdk5 for killing of breast cancer cells via perturbation of redox homeostasis

https://doi.org/10.18632/oncoscience.431

Saranya  NavaneethaKrishnan, Jesusa L. Rosales, Ki-Young  Lee

p 152-154

PDF

An oncogenic role for microRNA-146b in the thyroid

https://doi.org/10.18632/oncoscience.432

Julia  Ramírez-Moya, Pilar  Santisteban

p 155-156

PDF

GPR50 in TGFβ signaling and breast cancer

https://doi.org/10.18632/oncoscience.433

Raise  Ahmad, Stefanie  Wojciech, Ralf  Jockers

p 157-158

PDF

KDM2B in papillomavirus-related cancer

https://doi.org/10.18632/oncoscience.434

Elektra  Peta, Giulia  Masi, Luisa  Barzon

p 159-160

PDF

Quantitative pharmacology in antibody-drug conjugate development: armed antibodies or targeted small molecules?

https://doi.org/10.18632/oncoscience.435

Ian  Nessler, Eshita  Khera, Greg M. Thurber

p 161-163

PDF

HDL and the golden key to cancer immunity?

https://doi.org/10.18632/oncoscience.436

Michael P. Plebanek, Debayan  Bhaumik, C. Shad Thaxton

p 164-166

PDF

The systemic control of cancers by the osteoblasts

https://doi.org/10.18632/oncoscience.437

Claire-Sophie  Devignes, Yetki  Aslan, Sylvain  Provot,   

p 167-168

PDF

Using interferon-beta to combat cancer stem cell properties in triple negative breast cancer

https://doi.org/10.18632/oncoscience.438

Mary R. Doherty, Mark W. Jackson

p 169-171

PDF

The BBN model: a mouse bladder cancer model featuring basalsubtype gene expression and MLL3/MLL4 genetic disruption

https://doi.org/10.18632/oncoscience.439

Damiano  Fantini, Joshua J. Meeks

p 172-173

PDF

Efferocytosis and prostate cancer skeletal metastasis: implications for intervention

https://doi.org/10.18632/oncoscience.440

Hernan  Roca, Laurie K. McCauley

p 174-176

PDF

A mechanism for cell non-autonomous inactivation of the tumor suppressor DAB2IP

https://doi.org/10.18632/oncoscience.441

Arianna  Bellazzo, Licio  Collavin

p 177-178

PDF

Macrophages as prognostic biomarkers in human melanoma

https://doi.org/10.18632/oncoscience.442

Rafael  Samaniego, Alba  Gutiérrez-Seijo, Paloma  Sánchez-Mateos

p 179-180

PDF

Reviews

Exosomes: mediators of bone diseases, protection, and therapeutics potential

https://doi.org/10.18632/oncoscience.421

Jyotirmaya  Behera, Neetu  Tyagi

p 181-195

Abstract |  PDF |  Full Text

Research Papers

The therapeutic properties of resminostat for hepatocellular carcinoma

https://doi.org/10.18632/oncoscience.420

Jun  Zhao, Steven G. Gray, Martin  Wabitsch, Catherine M. Greene, Matthew W. Lawless

p 196-208

Abstract |  PDF |  Full Text |  Supplementary Material